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Abstract: CD4 decline is a hallmark of disease onset in individuals infected with Feline 
Immunodeficiency Virus (FIV) or Human Immunodeficiency Virus type 1 (HIV-1). Cats 
that are infected with a poorly replicating, apathogenic FIV (PLV) prior to exposure to a 
virulent FIV strain (FIVC) maintain CD4 numbers by mechanisms that are not correlated 
with a measurable adaptive immune response or reduction in circulating viral load. We 
employed population genetic approaches based on the 3' portion of the viral genome to 
estimate  the  population  structure  of  FIVC  from  single  and  dual  infected  cats.  In  dual 
infected  cats,  FIVC  effective  population  size  was  decreased  during  the  initial  viral 
expansion phase, and after three weeks of infection, the population declined sharply. The 
FIVC population recovered to pre-bottleneck levels approximately seven weeks post-FIVC 
infection. However, the population emerging from the bottleneck in dual infected cats was 
distinct based on estimates of temporal population structure and substitution profiles. The 
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transition to transversion rate ratio () increased from early to late phases in dual infected 
cats due primarily to a decrease in transversions whereas in single infected cats,  declined 
over  time.  Although  one  clone  with  extensive  G  to  A  substitutions,  indicative  of  host 
cytidine deaminase editing, was recovered from a dual infected cat during the bottleneck, 
the post bottleneck population had an overall reduction in G to A substitutions. These data 
are  consistent  with  a  model  of  PLV-induced  host  restriction,  putatively  involving  host 
DNA editing, that alters the dynamics of FIVC throughout the course of infection leading 
to disease attenuation. 
Keywords:  Lentivirus;  dual  infection;  population  genetics;  genetic  bottleneck;  viral 
temporal dynamics; mutation rate  
 
1. Introduction 
Lentivirus  infections  cause  profound  changes  in  immune  function  reflected  by  alterations  of 
circulating T cell phenotype, most notably decline of CD4 T cells, in infected felines and humans. To 
date,  the  most  effective  and  widely  used  therapeutic  intervention  strategies  aim  to  reduce  viral 
replication with specific inhibitors of different parts of the virus life cycle; immunological correlates of 
protection against disease are poorly understood. There are intriguing reports that a preexisting virus 
infection can ameliorate disease when an individual becomes infected with a virulent lentivirus. For 
example, a primary HIV-2 infection delays the onset of AIDS in individuals who secondarily are 
infected with HIV-1 [1]. Hepatitis G virus has also been reported to attenuate HIV-1 infection in vivo 
and in vitro [2]. In both cases, the mechanisms of disease attenuation are unclear but do not appear to 
be solely due to host adaptive immunity.  
The mechanism by which a preexisting apathogenic lentivirus infection protects against disease 
caused  by  a  virulent  lentivirus  can  be  explored  experimentally  using  cats  infected  with  Feline 
Immunodeficiency Virus (FIV). Cats experimentally infected with a pathogenic molecular clone of 
FIV subtype C (FIVC36; FIVC hereafter) develop an AIDS-like syndrome that is very similar to that 
observed for human AIDS [3]. If cats were initially infected with an apathogenic lentivirus derived 
from a wild cougar, strain poorly replicating, apathogenic FIV (PLV), they did not experience CD4 
decline and neutropenia when co-infected with FIVC [4,5]. As with HIV-1 coinfections, the altered 
outcome of infection did not appear to be due to host adaptive immunological responses.  
In this report, we evaluated the effect of PLV on FIVC infection dynamics by analyzing virus 
population genetic structure. The null hypothesis is that if there is no effect of PLV on FIVC, genetic 
variability in FIVC should be similar in the single and dual infection environment. On the other hand, 
if  our  analyses  indicate  that  different  FIVC  population  genetics  profiles  exist  in  single  and  dual 
infections,  the  parameters  that  differ  between  the  two  populations  will  inform  the  mechanism  of  
PLV-induced protection. The extent of genetic variations and associated factors can be evaluated by 
estimating several population genetic parameters. Whereas the census population size represents a total 
count of viral particles, the effective population size, Ne (θ = 2Neμ) [6] is implicitly associated with the 
mutation rate (μ) and represents the number of parental virions contributing genetic information to Viruses 2010, 2  2665 
 
successive generations. Thus, differences in census and effective population size can inform important 
interactions that occur in complex coinfection systems such as the one under study. The viral effective 
population size is inversely associated with random genetic drift. Thus, the effect of genetic drift will 
be  stronger  on  viruses  with  smaller  effective  population  size  and,  as  a  consequence,  the  overall 
mutation rate in this population would be higher. Stochastic processes as defined by drift have been 
recognized as determinants that change the genetic makeup of several RNA viruses  [7] including 
lentiviruses [8–11]. This is particularly important because, in a neutrally evolving population, genetic 
drift can reduce the overall genetic variation and, consequently, fitness in the population; a concept 
explained by Muller's ratchet [12]. Muller‟s ratchet predicts that genetic drift and associated higher 
mutation  rate  in  a  small  asexual  population  will  cause  an  excess  of  deleterious  mutations  to 
accumulate, which eventually leads to a genetic bottleneck. Although there is increasing evidence on 
the operation of Muller ratchet in RNA viruses [13–18], with few exceptions [19–21], evidence of 
Muller‟s ratchet is limited to lentiviruses.  
The main objective of the present study was to determine whether a virulent FIVC strain exhibited a 
genetic profile unique to the dual infection environment. We evaluated the rate of evolution, patterns 
of nucleotide substitution, population genetic structure, and population dynamics of FIVC from single 
and dual infected cats. Our results demonstrate that PLV infection impacts FIVC throughout the course 
of  infection.  These  data  are  significant  because  they  suggest  that  disease  prevention  induced  by 
previous infection with an attenuated virus is more closely associated with changes in viral dynamics 
than to known correlates of host adaptive immunity. 
2. Results and Discussion 
2.1. FIVC Genetic Diversities and Population Dynamics Differ Significantly Between Single and Dual 
Infection Environments  
To determine the population genetic features of FIVC in single and dual infection environments, we 
estimated viral genetic diversity indices using distance-based summary statistics (Table S1). Tajima‟s 
D for FIVC in single (D = −2.94749) and dual (D = −2.94989) infected groups were significantly less 
than zero (p < 0.001). This indicated that, compared to expectations for neutrally evolving populations, 
rare alleles were in excess in both single and dual infection environments and the populations were 
expanding or under purifying selection. We next performed Bayesian skyline analyses [22,23] because 
Tajima's  D  estimates  do  not  capture  temporal  dynamics  of  these  viral  populations.  The  mean 
coefficient of variation (CoV) of FIVC in single and dual infection environments was very high. In 
neither case did the lower 95% highest-posterior density (HPD) encompass zero (Table 1), which 
indicated  that  there  were  large  scale  rate  heterogeneities  among  viral  isolates  in  both  infection 
environments and the populations were not exhibiting clock-like behavior. The mutation rate of FIVC 
in dual infected cats was higher than that of single infected cats and there was no overlapping of 95% 
HPD. The Bayesian skyline plot (BSP) revealed that both FIVC populations showed sudden expansion 
during the first week of infection (Figure 1). However, the effective population size of FIVC in dual 
infected cats was significantly smaller than the FIVC population in the single infection environment 
with no overlapping of 95% HPD. Further, while FIVC in the single infection environment remained 
stable  for  the  duration  of  the  experiment,  there  was  a  sharp  population  decline  representing  a Viruses 2010, 2  2666 
 
bottleneck from day 21 to 45 post FIVC infection in FIVC from dual infected cats (Figure 1). The 
virus population recovered from this marked restriction in genetic diversity by approximately seven 
weeks post-infection and was stable thereafter. However, effective FIVC population size remained 
lower in dual vs. single infection (Figure 1). 
Table 1. Mutation rates of FIV genome in single and dual infected cats. 
Group  Clock model  Mutation rate (×10
−5/site/day)  CoV* 
Single  Strict  10.60 (9.23–12.5)  N.A 
  Relaxed  4.60 (4.21–5.00)  0.866 (0.698–1.057) 
Dual  Strict  11.3 (9.87–12.9)  N.A 
   Relaxed  6.94 (5.27–8.12)  0.884 (0.681–1.116) 
Estimates are based on the HKY model with uncorrelated log-normal distribution (UCLD) and 
Time  to  the  Most  Recent  Common  Ancestor  (TMRCA)  was  constrained  (90  days);  
*CoV: Coefficient of Variation. N.A: Not applicable. 
 
Figure  1.  FIVC  genomic  diversity  in  dual  and  single  infection.  Bayesian  skyline  plot 
depicting dynamics of FIVC effective population size in single (grey) and dual (black) 
infections. Thick  lines indicate median  values  and  dotted lines  indicate 95%  confident 
intervals. The time scales are referenced to the day of PLV infection, and to the day of FIVC 
infection, which occurred 28 days after cats were infected with PLV. Shading highlights 
severe constriction of effective population size, indicative of a population bottleneck. 
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2.2. Temporal Population Structure 
The Bayesian skyline analysis suggested that the viral populations in each infection environment 
could  be  temporally  structured.  To  investigate  this  possibility,  the  data  were  partitioned  into  four 
groups: single-early (SE), single-late (SL), dual-early (DE), and dual-late (DL) and the genetic variances 
were evaluated using analyses of molecular variance (AMOVA). The genetic variances attributed to 
among groups (single vs. dual) were not significant (Table 2), which was expected because total genetic 
variation was averaged across time points in this analysis. However, there was significant genetic 
differentiation  between  SE  and  SL,  and  between  DE  and  DL  (p  <  0.001),  indicating  temporal 
structuring  of  FIVC  populations  in  both  single  and  dual  infection.  Further,  pairwise  FST  analyses 
showed that DL was significantly different from the other groups (p < 0.0001). A neighbor-joining tree 
based on pairwise FST showed that DL was an out-group to the other three groups (Figure 2). Thus, the 
dual late FIVC population, which represents the population that recovered from a bottleneck event 
(Figure 1), showed unique population structuring.  
Table  2.  Analyses  of  Molecular  Variance  (AMOVA)  showing  the  hierarchical  genetic 
partitioning in FIV from single and dual infections. 
Source of     Sum of  Variance  Percentage  Fixation  
variation  d.f.  squares  components  of variation  index 
Among                
groups  1  11.208  −0.01690 Va  −0.14  FCT: −0.00175 
           
Among           
populations           
within groups  2  24.364  0.08847 Vb  0.92  *FSC: 0.00915 
           
Within           
populations  114  1092.68  9.58492 Vc  99.26  *FST: 0.00741 
           
Total  117  1128.25  9.65649       
The data was partitioned into four temporally-spaced populations: single early (SE), single late 
(SL), dual early (DE) and dual late (DL). Single group include SE and SL, and dual group include 
DE and DL; Va, Vb, and Vc are the associate covariance components. FCT, FST, and FSC are the  
F-statistics; * Significant values at P < 0.001 after 10,000 permutations. 
 
2.3. Pattern of Nucleotide Substitution 
The temporal and spatial genetic structure in a neutrally evolving population is presumably due to 
stochastic mutational processes. However, forces such as rapid adaptation to the locality by natural 
selection can contribute significantly to population genetic structure. We therefore investigated the 
nature of selection and mutational profile to enhance our understanding of the mechanisms leading to 
the unusual FIVC genetic structuring detected in dual infected cats. The overall dn/ds values for all 
protein coding genes ranged from 0.2 to 5.1 (95% HPD) (Table S2), but none of the codons in any Viruses 2010, 2  2668 
 
gene were detected as positively selected. This supports our earlier findings (Table S1) that purifying 
selection was the major driving force in the evolution of FIVC in both infection environments.  
Figure 2. Clustering of FIVC from dual and single infections. FST-based neighbor joining 
tree  showing  the  relationships  among  the  temporally-spaced  infection  groups.  Branch 
lengths are shown at the base of the respective nodes. 
 
 
Early in the course of infection, transitions, which typically cause synonymous changes, are more 
frequent  than  transversions,  which  more  often  cause  a  change  in  amino  acid.  We  compared  the 
transition to transversion rate ratio (kappa, ) for the dUTPase/integrase portion of pol (ui), vif and env 
of each of the four groups (Table 3). Our results revealed that  was increased two- to three-fold in 
dual late compared to dual early FIVC genomes. In contrast, there was a reduction in  from the early 
to late phase in FIVC from single infected cats (Table 3). There was a two- to four-fold increase in  
from FIVC in the dual late compared to single late infection environment.  
Table 3. Transition and transversion rate ratio (kappa, k) for ui, vif, and env genes at early 
and late time point of single and dual infection groups. 
   ui     vif     env 
Kappa (k = Ts/Tv)  Early  Late    Early  Late    Early  Late 
Single  17.1712  10.2651     9.0782  7.88854     14.8736  7.88854 
                    
Dual  8.868  20.1281     10.2285  33.0202     13.6558  26.5212 
Horizontal dark grey shading shows the trend from early to late for each gene of the respective 
infection group. The vertical light grey shading shows the trend in late phase. 
 
Increase  in  the  value  of    could  be  due  to  an  overall  increase  in  transitions  or  a  decrease  in 
transversions. We evaluated the nature of the substitution bias in dual late FIVC sequences because our 
previous studies on PLV evolution in cats demonstrated a significant impact of cytidine deaminase Viruses 2010, 2  2669 
 
activity on viral genomes concomitant with an increased rate of G to A substitutions [24]. Analysis 
revealed two distinct phenomena. (1) A single clone from dual infected cat 4196 at day 17 post-FIVC 
infection  was  confirmed  to  be  G  to  A  hypermutated  using  the  hypermut  2  and  HperPack  [25] 
programs. Approximately 155 of 175 mutations in the 4604 bp sequence were G to A substitutions  
(p  <  0.000001)  (Figure  3).  (2)  The  pattern  of  nucleotide  substitutions  in  the  remaining  
non-hypermutated  sequences  was  evaluated  using  phylogeny-based  simulation  as  described  in  the 
Materials  and  Methods  section.  OrfA  was  excluded  because  it  contained  few  nucleotide 
polymorphisms.  Although  the total  number  of  T  to  C  substitutions  was  higher in  vif in  dual  late 
genomes versus the rest of the groups, transitions were not overrepresented in FIVC from dual infected 
cats (Figure S1). In fact, G to A substitutions were lowest in the dual late group (Figure 4A). With the 
exception of A to T substitutions, the percentage of all other possible transversions in dual late FIVC 
sequences was lower than in other groups (Figure 4B). These results indicate that the increase in κ in 
FIVC from dual early to dual late was due to a decline in transversions, not an increase in transitions. 
By contrast, the percentage of each transversion typically increased from early to late groups in single 
infections, which was reflected in a marginal decrease in κ (Table 3).  
Figure 3. Nucleotide substitution frequency in a hypermutated clone from a dual infected 
cat. (A) Plot of percentage A versus G for all clones in all the four groups. The outlier 
clone, dF96B68_d45, is identified in the upper left quadrant. (B) Specific mutations noted 
in the hypermutated clone relative to parental virus. Inset indicates non-G to A transitions 
on an expanded scale.  
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Figure 4. Percentage of substitutions in early and late populations in FIVC sequences from 
single and dual infections. (A) Percentage of total substitutions in each gene that are G to A 
substitutions. Dual late FIVC genomes have the lowest percentage of G to A substitutions. 
(B) Percentage of total substitutions in each gene that are each possible transversion. The 
di-nucleotide symbol indicates that the first nucleotide is replaced by the second, e.g., GT 
indicates a G to T substitution. Data are shown for three genes; ui is the 3' end of the pol 
gene encoding dUTPase and integrase.  
 
 
2.4. Discussion 
We have previously demonstrated that a primary infection with apathogenic PLV prevented the 
onset  of  CD4  decline  induced  by  a  subsequent  infection  with  pathogenic  FIVC  when  challenge 
occurred  28  days  after  PLV  infection.  PLV  infection  did  not  significantly  alter  FIVC  proviral  or 
plasma load and did not induce FIVC specific serum neutralizing antibodies [4]. In the present study, 
we investigated discernable effects of PLV infection on FIVC population dynamics using population 
genetics approaches. Our data indicate that, despite low levels of replicating PLV, there is a profound 
and prolonged effect of PLV on FIVC infection. A model summarizing these impacts is presented in 
Figure 5 and discussed below. 
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Figure 5. Schematic model of the dynamics of FIVC in single and dual infection. Key 
elements  of  FIVC  infection  dynamics  in  dual  infected  cats  are  indicated  with  letters.  
A:  Initial  infection  of  10  cats  with  PLV  or  sham  inoculated.  B:  (28  days  post  PLV 
infection);  Infection  of  five  cats  in  each  group  with  FIVC  (4  groups  total).  C:  Peak 
effective population size one week after FIVC infection. D: Population bottleneck between  
week 3–7 in dual infected cats. E: FIVC recovery from bottleneck. The black and grey 
lines represent changes in FIVC effective population size from dual and single infected 
cats, respectively. The circles along the lines are proportional to FIVC population size in 
PBMC and circles adjacent to the line represent hypothetical dynamics of virus infection in 
peripheral tissues. The number and color of dots in each tissue „circle‟ represent genetic 
diversity  in  each  FIVC  population.  Possible  mechanisms  for  the  bottleneck  related  to 
changes in infected cell dynamics include decreased immigration of infected cells from 
peripheral tissues to blood (dashed arrow) or increased emigration from peripheral blood to 
tissues  (bold  arrow).  The  recovered  population  (E)  in  dual  infected  cats  has  unique 
substitution features (see text) suggesting that the majority of infected cells sampled in 
peripheral blood might be coming from a tissue compartment or cell type not represented 
in the pre-bottleneck sample (indicated by the curved arrows). An alternative explanation is 
that the recovered population derives from a genetically impoverished population depicted 
at D that survived the bottleneck. The population size of FIVC in single infection is stable 
throughout this period (C–E).  
 Viruses 2010, 2  2672 
 
In the week following challenge, FIVC populations in both single and dual infected cats rapidly 
expanded. However, in dual infected cats, the effective population size of FIVC was significantly 
smaller than for FIVC in the single infection environment. The lower FIVC population size in dual 
infected cats could be a direct consequence of a decrease in available susceptible target cells by PLV. 
However, there are no data to indicate that availability of susceptible cells is a limiting factor for FIVC 
infection in general, and in our study, there were no significant differences in blood counts of naïve 
and PLV-infected cats [4]. Although we did not detect anti-FIVC neutralization titers or cell mediated 
immune parameters  [4], it is possible that PLV-generated effective humoral or cellular immunity, 
which  was  below  our  limits  of  detection.  More  detailed  evaluation  is  required  to  rule  out  this 
possibility.  A  third  consideration  is  that  prior  PLV  infection  resulted  in  a  host  environment  with 
residual or primed target cells poised to raise a more effective innate response, which limited the 
ability of FIVC to infect or replicate in some cells. This is an intriguing possibility in light of our 
previous observations implicating cytidine deaminase editing during PLV infection [24]. Our finding 
of one  hypermutated FIVC clone  from a  dual infected  cat  at the onset of the bottleneck and the 
significant decline of G to A substitutions in the recovered population suggests that cytidine deaminase 
activity could be involved in the reduction of FIVC population size in dual infection; this possibility 
merits more thorough investigation.  
After the expansion phase, the FIVC effective population size in the dual infection environment was 
stable for two weeks followed by a sharp population decline. There are several plausible mechanisms 
to  account  for  the  FIVC  bottleneck.  The  immunocyte  population  that  supports  productive  FIVC 
infection could be markedly reduced in the face of persistent PLV activation, although as noted above, 
cell counts and phenotypes were similar in dual and single infected animals. We note that our samples 
come from provirus in circulating PBMC representing a mix of infected cells moving into and out of the 
blood from various tissues. Tissue compartmentalization of lentiviruses is well documented [26–37]. 
Thus, without evoking differences in individual cell infection or production rates, changes in migration 
patterns  of  infected  PBMC  from  blood  to  tissue  could  lead  to  the  difference  in  effective  FIVC 
population size in dual and single infections. For example, either sequestration of infected PBMC in a 
solid tissue, such as lymph node or bone marrow, or increased emigration of infected cells out of the 
circulation  to  sites  of  inflammation  in  dual  infected  cats  are  consistent  with  our  results.  It  is 
noteworthy  that  near  day  24  post-FIVC  infection,  dual  infected  cats  developed  a  distinct 
immunological profile in PBMC, which consisted of elevated numbers of CD8 and CD25 cells and 
higher  expression  of  IL4,  FAS,  and  IFNγ  [38].  The  bottleneck  corresponded  temporally  to  the 
development  of  this  pro-inflammatory  immunological  profile  [38],  and  to  transient  restriction  of 
proviral load [4], in dual infected cat PBMC. This is the only time point at which there is sufficient 
signal in the census population size to reflect the decrease in effective population size, which suggests 
that many provirus containing cells are not productively infected. Cumulatively, these data support that 
a  unique  immunological  environment,  which  could  be  tissue  specific  but  is  transiently  reflected 
peripherally, in dual infected cats contributed to the FIVC population decline.  
Restriction in effective population size by any mechanism discussed above will increase the impact 
of genetic drift because there is a stronger effect of drift on populations with lower effective population 
size. We observed both lower effective population size and higher mutation rate of FIVC in dual 
infection environment, suggesting that drift might have contributed to the observed bottleneck. In a Viruses 2010, 2  2673 
 
viral  population  with  smaller  effective  population  size,  accelerated  rates  of  mutation  can  also  be 
caused  by  positive  selection,  which  tends  to  rapidly  fix  beneficial  mutations  in  the  population. 
However,  we  found  no  evidence  of  positive  selection  pressures  in  either  single  or  dual  infection 
environments.  Accumulation  of  deleterious  mutations  is  another  consequence  of  drift  on  small 
populations. This effect, called Muller‟s ratchet [12], can lead to a genetic bottleneck due to loss of 
fitness and has been reported for HIV-1 [19–21] and for several other RNA viruses [13–18]. The 
gradual accumulation of deleterious mutations due to drift could be accelerated by cytidine deaminase 
editing of viral genomes, which renders many genomes defective [24]. 
FIVC populations in dual infected cats recovered to initial levels approximately seven weeks post 
FIVC infection and remained constant and consistently lower than FIVC in single infected cats for the 
duration of the experiment. Populations recovering from a bottleneck could have decreased fitness 
because most of the genetic variation had been eliminated. Thus, the nature of the population that 
reestablished the FIVC population is important for understanding long term clinical consequences of 
dual  infection.  We  used  population  genetics  approaches  to  determine  how  the  late  populations 
compared to those that established infections in dual and single infected cats. The AMOVA results 
demonstrated that there was temporal structure in both infection environments. Temporal population 
structure, which is the sequential replacement of virus genotypes over time, has been described for 
HIV-1 infections in blood and tissues [32], and is expected given the mobility patterns of circulating T 
cells. However, based on FST analyses, temporal structure was more pronounced in the dual infection 
environment. These data are consistent with the hypothesis that the recovered population derived from 
a cell type that is poorly represented in single infected cats and at early time points. The specific 
pattern of substitutions was also revealing of differences in temporal population structure that occurred 
in the presence or absence of a bottleneck. Transversions are more likely to cause non-synonymous 
changes that accumulate as deleterious substitutions are purged and the population evolves to greater 
fitness. If the late population is descendant from the early population and did not experience a genetic 
bottleneck, one would expect a higher number of transversions in the late population. This was, in fact, 
noted for FIVC genomes from single infected cats; the value of  for FIVC in the early population was 
higher than that of the late population. However, there was an unusually high value of  in dual late 
compared to dual early FIVC populations. We show that this was due to a decrease in the number of 
transversions rather than an increase in transitions. This is consistent with the premise that proviral 
genomes  emerging  from  the  bottleneck  have  lower  fitness;  they  carry  an  excess  of  deleterious 
mutations, which have not yet been purged from the population [19]. 
The dual late FIVC population had a significantly lower number of G to A substitutions compared 
to any of the other populations. An excess of G to A substitutions can occur through enzymatic editing 
mechanisms [24,39–41] which was evident from the single clone from a dual infected cat (Figure 3), 
or through misincorporation of dUTP [42]. The lentivirus accessory gene vif protects against cytidine 
deamination of the viral genome [40,43]. Cell type specific expression of human cytidine deaminases, 
APOBECs, has been demonstrated in humans; additionally, regulation of APOBECs expression by 
innate  effectors  is  also  tissue  specific  [44].  FIV  also  encodes  a  dUTPase,  which  decreases  the 
incorporation  of  uracil  into  the  newly  synthesized  viral  DNA.  Defects  in  viral  dUTPase,  which 
increase overall mutation rate, can be overcome in actively replicating cells, which express high levels 
of cellular dUTPase [45]. Our findings of a low level of G to A substitutions are consistent with the Viruses 2010, 2  2674 
 
data  on  tissue  specific  expression  and  regulation  of  host  restriction  factors  responsible  for  this 
substitution bias. Thus, FIVC-infected PBMC sampled in the blood of dual infected cats may be derived 
from a tissue compartment or cell type where host restriction is relaxed. The lower effective population 
size after recovery from the bottleneck would indicate that this site is not optimal for FIVC replication. 
Our data cumulatively support a model for long term, and potentially cell or tissue specific, innate 
immune priming that substantially alters FIVC genomic population structure following PLV infection. 
This work significantly contributes towards understanding the mechanism by which attenuated viruses 
control disease caused by more virulent strains in the absence of known adaptive immune responses. If 
confirmed by additional experiments, this mechanism could elucidate a sustained phenotype for innate 
immunity that is instrumental in lentivirus control and lead to novel therapeutic avenues. 
3. Materials and methods 
3.1. Experimental Design, Cloning, and Sequencing 
Detail on the experimental design was reported in Terwee et al. [4]. Briefly, two groups of 10 cats 
each were inoculated with PLV or sham inoculated at day 0. At day 28, five cats in each group were 
inoculated intravenously with the molecular clone FIVC36 (FIVC hereafter) [3]. Blood samples from 
day 17, 52, 80/87 post-FIVC challenge (days 45, 80, 108/115 post-PLV) were used to obtain FIVC 
sequence  data.  All  animal  work  was  conducted  under  approval  of  the  Colorado  State  University 
Animal Care and Use Committee. 
Sequencing of a 4604 bp of the 3' end of the FIVC genome from four cats in the PLV + FIVC group 
(dual infected) and four cats in the FIVC only group (single infected) was carried out using previously 
described  protocols  [24].  The  primers  for  nested  PCR  amplification  were  3FIVC5F 
(5'CTGCCAGGAGAAGTAAAAGTAA)  and  3FIVC6R  (CTCAAAGGGAAGAAATCAGC).  First 
and second round amplification conditions were 35 cycles of 95 °C denaturation (30 s), 52 °C anneal 
(30 s), 72 °C extension (5 min). Second round primers contained NotI and BamHI restriction sites and 
conditions  were  3FIVC7NotF  (CCTGCGGCCGCTTGGGGATTGATACTTG)  and  3FIVC8BamR 
(CGGAGGATCCACATTGCCTACCATTTCT).  An  annealing  temperature  of  54  °C  was  used  for 
second round PCR. Products were gel purified, digested with the appropriate enzyme and cloned into a 
Not1 and BamH1 digested pBS vector. For each cat, 7 to 8 clones derived from different first round 
PCR  were  sequenced.  DNASTAR  software  package  (DNASTAR  Inc.  WI,  USA)  was  used  for 
sequence assembly, editing, and alignment. The inoculating sequence (AY600517) was used as the 
reference sequence for alignment. A total of 151 sequences (dual: 78 and single: 74), which included 
four coding genes (dUTPase and integrase region of pol (ui), vif, orfA, and env) were obtained. One 
clone  from  day  17  of  a  dual  infected  cat  (4196)  was  hypermutated  and  was  excluded  from  the 
population genetic analyses. 
3.2. Estimates of Genetic Diversities and Population Dynamics 
We took two approaches to characterize the evolutionary genetics of FIVC in the dual and single 
infection environments. Our first analyses employed distance-based summary statistics [46,47], which 
are independent of time. This approach determines differences in genetic diversities between two viral Viruses 2010, 2  2675 
 
populations  arising  from  variation  in  effective  population  size,  differential  selection  pressures, 
recombination events, and migration among tissue compartments. The two indices of genetic diversity 
estimated here are θw [47] and θπ [46]. The parameter θw is based on the number of segregating 
(polymorphic) sites in the data set; the parameter θπ is based on pairwise differences. Tajima‟s D was 
used to determine the intensity of selection pressure and to explore the population history of each viral 
population [48]. The genetic diversity indices were estimated using the DNAsp version 5 [49].  
While population history may be inferred using statistics such as Tajima‟s D [48] and Fu‟s Fs [50], 
unique events that occurred in the past will not be revealed with these estimates because they are 
independent of time. A Bayesian coalescent approach is more appropriate to infer past changes in 
population size from serial sampled data collected from a population [22,23], which make no prior 
assumptions  about  population  history.  Therefore,  our  second  approach  was  to  perform  Bayesian 
skyline plot (BSP) analyses using BEAST version 1.4.8 [22] to infer the dynamics of FIVC in single 
and dual infection environments. The HKY + G was the best-fit nucleotide substitution model for each 
data set selected by the hierarchical likelihood ratio tests (hLRTs) as implemented in the Modeltest 
version 3.7 [51]. A simple HKY model of nucleotide substitution, both with the strict molecular clock 
and with the relaxed clock under uncorrelated log-normal distribution (UCLD) was used to avoid  
over-parameterization  due  to  the  limited  diversity  and  sampling  time  range  with  our  data.  The 
coefficient of co-variation (CoV) inferred from the relaxed model of the respective group was used as 
an  indicator  of  the  extent  of  rate  heterogeneities  in  each  viral  lineage.  If  the  95%  HPD  of  CoV 
encompasses zero, then clock-like behavior cannot be rejected. MCMC chains were run for a total  
of 100 million generations and 1% burnin was discarded from each chain. MCMC chains were run 
multiple times and the convergence was checked using Tracer 1.4 [52]. Since all clones were derived 
within  the  87  days  after  challenge  with  FIVC,  the  TMRCA  was  constrained  to  90  days.  The 
uncertainty in the data is reflected in the 95% HPD intervals. The BSP [23] provided estimates of 
effective population size, in terms of relative genetic diversity, for virus populations replicating in 
single and dual infection environments. 
3.3. Analyses of Temporal Population Structure 
To examine the temporal population structuring, we partitioned the data into four groups: single 
infection-early (SE), single infection-late (SL), dual infection-early (DE), and dual infection-late (DL). 
The early time point referred to the samples collected at day-17, and late time point referred to the 
samples collected at day-80/day-87 post FIVC infection. Analyses of molecular variance (AMOVA) 
were carried out using the Arlequin version 3.1 [53] to evaluate how the genetic variances in these four 
infection  groups  are  partitioned.  This  is  a  genetic  distance-based  test  that  first  estimates  pairwise 
distances within and between predefined groups and then partitions the covariance components to the 
respective groups. The total molecular variance can be divided into the covariance component due to: 
(a) differences among individuals within single and within dual infection environment (FST), (b) a 
covariance component due to differences between early and late populations within single and within 
dual infection environments (FSC), and (c) a covariance component due to differences between single 
and dual infection environments (FCT). The significance of the covariance components is tested using 
non-parametric permutation procedures [54]. Statistical support is determined non-parametrically by 
permuting group assignments 10,000 times. The pair-wise genetic distances measured as FST [55] Viruses 2010, 2  2676 
 
among the four groups were also estimated using Arlequin and their significance were determined  
non-parametrically  with  10,000  simulations.  The  FST  matrix  was  used  to  reconstruct  the  neighbor 
joining tree using the NEIGHBOR program as implemented in PHYLIP version 3.69 [56]. 
3.4. Pattern of Nucleotide Substitutions 
3.4.1. Selection Analyses 
We performed codon specific selection analyses on each protein coding gene (ui, vif, orfA, and 
env) using the maximum likelihood based codon substitution model implemented in CODEML of 
PAML version 4.1 [57], and Fixed Effects Likelihood (FEL) and Single Likelihood and Ancestor 
Counting  (SLAC)  methods  implemented  in  the  datamonkey.org  web  server  [58].  To  avoid  the 
possibility of false positives, we considered a codon to be under positive selection if that site was 
identified by both methods. The transition: transversion rate ratio (Kappa, κ) for each gene at each time 
point was estimated using CODEML.  
3.4.2. Substitution Bias 
Prior to further genetic analyses, all the sequences were analyzed for hypermutation by the cytidine 
deaminase editing mechanism using  the Hypermut 2 [59]  and HyperPack [25] software using the 
inoculating sequence (AY600517) as the parental sequence. 
Alignments were developed from 3'-genome FIVC sequences obtained for clones sequenced from 
PBMC either early (day 17) or late (day 80 or 87) post-infection. Separate alignments were established 
for ui, vif, OrfA, and env genes. The sequence for the corresponding gene region in AY600517 was 
included in each alignment as an outgroup. Further, larger (“combined”) alignments were developed 
by including all of the sequences available for each combination of time (early, late) and infection state 
(single, dual). The substitutions occurring in each evolutionary history were characterized by phylogenetic 
analysis. A phylogenetic tree was estimated for each sequence alignment using PAUP* [60] with the 
GTR  +  G  model  of  evolution.  The  tree  then  formed  the  basis  for  estimating  the  occurrence  of 
nucleotide substitutions; BASEML, a part of PAML v4.1 [57], was used to infer the ancestral states at 
each internal node of the tree. We assessed whether the substitutions occurred randomly with respect 
to local sequence context by comparing the observed results with those obtained by random sequence 
evolution.  The  evolution  of  sequences  at  random  with  respect  to  local  context  was  simulated  in  
Seq-Gen  v1.3.2  [61],  using  the  inferred  phylogenetic  tree  and  the  parameters  inferred  from  it. 
Simulated sequence evolution was performed for 100 replicates for each evolutionary history. For each 
alignment  and  type  of  substitution,  the  relative  frequency  of  each  di-nucleotide  context  was 
determined. From the 100 replicates, the distributions of these relative frequencies were determined. 
An  observed  context  was  judged  to  be  significantly  under-represented  if  it  fell  below  the  5  or  1 
percentiles of the distribution, or over-represented if it were above the 95 or 99 percentiles. The four 
treatment effects (single early, single late, dual early, dual late) were investigated using the combined 
sequence alignments. Viruses 2010, 2  2677 
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